|

Reslizumab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Cinqair

Pipeline

Phase 2: 1

Top Sponsors

  • National Jewish Health1

Indications

Denver, Colorado1 trial

Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

National Jewish Health

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.